ATE467690T1 - Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern - Google Patents

Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern

Info

Publication number
ATE467690T1
ATE467690T1 AT07007809T AT07007809T ATE467690T1 AT E467690 T1 ATE467690 T1 AT E467690T1 AT 07007809 T AT07007809 T AT 07007809T AT 07007809 T AT07007809 T AT 07007809T AT E467690 T1 ATE467690 T1 AT E467690T1
Authority
AT
Austria
Prior art keywords
polypeptides
synthetic antigen
detecting hiv
immunoreactive antibodies
immunoreactive
Prior art date
Application number
AT07007809T
Other languages
English (en)
Inventor
Patrick F Coleman
Carol-Ann Cole
Su Peter Chong-Dug
Alice Goshorn
Nobuo Monji
Original Assignee
Bio Rad Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Laboratories filed Critical Bio Rad Laboratories
Application granted granted Critical
Publication of ATE467690T1 publication Critical patent/ATE467690T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT07007809T 1997-08-01 1998-07-31 Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern ATE467690T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US90482697A 1997-08-01 1997-08-01

Publications (1)

Publication Number Publication Date
ATE467690T1 true ATE467690T1 (de) 2010-05-15

Family

ID=25419850

Family Applications (2)

Application Number Title Priority Date Filing Date
AT98938310T ATE360709T1 (de) 1997-08-01 1998-07-31 Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus
AT07007809T ATE467690T1 (de) 1997-08-01 1998-07-31 Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT98938310T ATE360709T1 (de) 1997-08-01 1998-07-31 Synthetische antigene zum nachweis von antikörpern mit immunreaktivität gegen hiv-virus

Country Status (9)

Country Link
US (1) US7144697B1 (de)
EP (2) EP1878805B1 (de)
JP (2) JP4166940B2 (de)
AT (2) ATE360709T1 (de)
AU (1) AU753780B2 (de)
CA (1) CA2298438C (de)
DE (2) DE69841664D1 (de)
ES (2) ES2344926T3 (de)
WO (1) WO1999006599A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003523721A (ja) 1998-12-31 2003-08-12 カイロン コーポレイション 抗原性ｈｉｖｃ型ポリペプチドをコードするポリヌクレオチド、ポリペプチド、およびそれらの使用
ES2400448T3 (es) 2001-04-30 2013-04-10 Ventana Medical Systems, Inc. Reactivos y métodos para la hibridación automatizada in situ o para microarray
US7211659B2 (en) 2001-07-05 2007-05-01 Chiron Corporation Polynucleotides encoding antigenic HIV type C polypeptides, polypeptides and uses thereof
US20070203325A1 (en) * 2006-02-24 2007-08-30 Xiaojian Yao Integrase-dirived HIV-inhibiting agents
PL2901157T3 (pl) * 2012-09-27 2022-05-02 Idexx Laboratories, Inc. Sposób wykrywania wirusa ze schmallenbergu (sbv) i zestaw
WO2020243485A1 (en) * 2019-05-29 2020-12-03 Massachusetts Institute Of Technology Hiv-1 specific immunogen compositions and methods of use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2519005B1 (fr) 1981-12-29 1985-10-25 Pasteur Institut Fragments d'adn marques a l'une au moins de leurs extremites par des ribonucleotides modifies reconnaissables par des molecules affines et procede pour realiser une analyse de tels fragments d'adn
US4629783A (en) * 1985-04-29 1986-12-16 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US5580739A (en) * 1986-01-22 1996-12-03 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
US5075211A (en) * 1986-03-26 1991-12-24 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US5206136A (en) * 1986-11-19 1993-04-27 Genetic Systems Corporation Rapid membrane affinity concentration assays
EP0283327B1 (de) * 1987-01-16 1997-06-25 Institut Pasteur Peptide mit den immunologischen Eigenschaften von HIV-2
US5221610A (en) * 1988-05-26 1993-06-22 Institut Pasteur Diagnostic method and composition for early detection of HIV infection
US5858646A (en) * 1989-02-23 1999-01-12 University Of Ottawa Modified HIV-pol polypeptide having immunological activity for use as diagnostic reagent
US5439792A (en) * 1989-06-02 1995-08-08 Genetic Systems Corporation Cysteine thiol-protected peptides for use in immunoassays
RU2043411C1 (ru) * 1992-01-05 1995-09-10 Биотехнологическая компания "Биосервис" Набор для определения антител к вирусу иммунодефицита человека первого и второго типов
RU2085586C1 (ru) * 1992-02-28 1997-07-27 Биотехнологическая компания "Биосервис" Полипептид 1106, предназначенный для определения антител к вирусу иммунодефицита человека первого типа, фрагмент днк н 1106, кодирующий полипептид 1106, рекомбинантная плазмидная днк рн 1106, кодирующая полипептид 1106, штамм бактерий escherichia coli - продуцент полипептида 1106
NZ263050A (en) * 1993-03-05 1997-11-24 Cytel Corp Compositions of immunogenic peptides with hla-a2.1 binding motifs

Also Published As

Publication number Publication date
US7144697B1 (en) 2006-12-05
ES2344926T3 (es) 2010-09-09
EP1878805B1 (de) 2010-05-12
EP1000177B1 (de) 2007-04-25
WO1999006599A1 (en) 1999-02-11
JP2001512037A (ja) 2001-08-21
EP1000177A1 (de) 2000-05-17
JP2005139204A (ja) 2005-06-02
EP1878805A2 (de) 2008-01-16
DE69837666T2 (de) 2007-12-27
DE69841664D1 (de) 2010-06-24
CA2298438A1 (en) 1999-02-11
EP1878805A3 (de) 2008-04-23
DE69837666D1 (de) 2007-06-06
ATE360709T1 (de) 2007-05-15
ES2286854T3 (es) 2007-12-01
AU753780B2 (en) 2002-10-31
AU8686098A (en) 1999-02-22
CA2298438C (en) 2010-10-05
EP1000177A4 (de) 2003-07-09
JP4166940B2 (ja) 2008-10-15

Similar Documents

Publication Publication Date Title
ATE116006T1 (de) Synthetische antigene zum nachweis von aids.
ES8708058A1 (es) Un metodo para detectar la presencia de virus lav-htlv-iii o de anticuerpo para virus lav-htlv-iii
ATE163766T1 (de) Synthetisches antigen zum nachweis von mit aids in zusammenhang stehenden krankheiten
ATE185350T1 (de) Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus
ATE109830T1 (de) Expression von virusproteinen mit immunologischer aktivität.
ATE467690T1 (de) Synthetisches antigen zum nachweis von hiv- immunreaktiven antikörpern
SE8902148L (sv) Syntetiska peptid antigen foer detektion av htlv-1 infektion
ATE108457T1 (de) Synthetische antigene zur bestimmung der aids- bezogenen, von lav-2 verursachten krankheiten.
ATE57262T1 (de) Verfahren zum nachweis von proteinen und viren.
SG145521A1 (en) Synthetic antigens for the detection of antibodies to hepatitis c virus

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties